BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.16B |
| 2 |
Apple
AAPL
|
+$981M |
| 3 |
Gilead Sciences
GILD
|
+$435M |
| 4 |
Magna International
MGA
|
+$420M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.97B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$502M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$471M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$338M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.71% |
| 2 | Financials | 10.13% |
| 3 | Consumer Discretionary | 9.04% |
| 4 | Healthcare | 8.33% |
| 5 | Communication Services | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Customers Bancorp
CUBI
$2.82B
| $137K | ﹤0.01% |
5,050
-600
| -11% | -$16.7K |
|
2102
Azenta
AZTA
$1.45B
| $137K | ﹤0.01% |
12,866
-1,214
| -9% | -$13.7K |
|
|
REV
2103
DELISTED
Revlon, Inc.
REV
| $137K | ﹤0.01% |
4,934
+1,113
| +29% | +$32.5K |
|
|
SNV
2104
DELISTED
Synovus
SNV
| $137K | ﹤0.01% |
4,232
-27,306
| -87% | -$871K |
|
2105
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.47B
| $137K | ﹤0.01% |
7,234
+438
| +6% | +$7.72K |
|
|
ARRY
2106
DELISTED
Array Biopharma Inc
ARRY
| $137K | ﹤0.01% |
32,432
+3,267
| +11% | +$14.9K |
|
|
CSFL
2107
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $137K | ﹤0.01% |
8,732
-793
| -8% | -$12.1K |
|
2108
M/I Homes
MHO
$3.87B
| $136K | ﹤0.01% |
6,214
+485
| +8% | +$11.1K |
|
2109
City Holding Co
CHCO
$2.08B
| $135K | ﹤0.01% |
2,966
-75
| -2% | -$3.6K |
|
|
RESI
2110
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $135K | ﹤0.01% |
10,902
-1,168
| -10% | -$16K |
|
|
CVGW
2111
DELISTED
Calavo Growers
CVGW
| $135K | ﹤0.01% |
2,754
-480
| -15% | -$24.4K |
|
2112
Quanex
NX
$960M
| $135K | ﹤0.01% |
6,456
-546
| -8% | -$10.5K |
|
|
RVNC
2113
DELISTED
Revance Therapeutics, Inc.
RVNC
| $134K | ﹤0.01% |
3,934
+651
| +20% | +$22.6K |
|
2114
Hovnanian Enterprises
HOV
$789M
| $134K | ﹤0.01% |
2,968
+22
| +0.7% | +$1.05K |
|
2115
Agree Realty
ADC
$9.35B
| $134K | ﹤0.01% |
3,930
+598
| +18% | +$19.5K |
|
2116
Helix Energy Solutions
HLX
$1.55B
| $133K | ﹤0.01% |
25,362
+4,507
| +22% | +$26.1K |
|
|
KCG
2117
DELISTED
KCG Holdings, Inc.
KCG
| $133K | ﹤0.01% |
10,836
+923
| +9% | +$11.5K |
|
2118
US Physical Therapy
USPH
$1.2B
| $133K | ﹤0.01% |
2,484
-79
| -3% | -$3.96K |
|
2119
ICF International
ICFI
$1.59B
| $132K | ﹤0.01% |
3,726
-399
| -10% | -$13.4K |
|
|
SGMO
2120
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $132K | ﹤0.01% |
14,480
+220
| +2% | +$1.7K |
|
2121
Globalstar
GSAT
$10.6B
| $132K | ﹤0.01% |
6,092
-583
| -9% | -$16.1K |
|
2122
LPL Financial
LPLA
$29.4B
| $131K | ﹤0.01% |
3,072
+1,831
| +148% | +$78K |
|
|
FPO
2123
DELISTED
First Potomac Realty Trust
FPO
| $131K | ﹤0.01% |
11,482
-256
| -2% | -$2.93K |
|
|
PDLI
2124
DELISTED
PDL BioPharma, Inc.
PDLI
| $131K | ﹤0.01% |
36,884
-126,333
| -77% | -$529K |
|
|
UNVR
2125
DELISTED
Univar Solutions Inc.
UNVR
| $131K | ﹤0.01% |
7,674
+203
| +3% | +$3.69K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2015 Portfolio in Review
As of Q4 2015, BNP Paribas Financial Markets held 3,765 positions worth $41.2B, up 3.1% from $39.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
BNP Paribas Financial Markets's Q4 2015 filing shows 160 new, 1,604 increased, 1,743 reduced and 193 closed positions. Its largest new stake was Alphabet (Google) Class A: 6,726,220 shares worth $262M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.97B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 8.7% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q4 2015 buy was Alphabet (Google) Class A: 6,726,220 shares worth $262M.
- BNP Paribas Financial Markets added most to Citigroup in Q4 2015, an estimated $1.16B increase.
- BNP Paribas Financial Markets's biggest Q4 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.97B.
- BNP Paribas Financial Markets fully exited iShares Russell 2000 Growth ETF in Q4 2015, selling an estimated $81.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 31% of its $41.2B portfolio in Q4 2015.
- BNP Paribas Financial Markets opened 160 new positions and closed 193 in Q4 2015.
- BNP Paribas Financial Markets's portfolio value rose 3.1% quarter-over-quarter to $41.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2015, filed 10 Feb 2016.